Study of the potential antifibrotic effects of carvedilol in exeperimental model of liver fibrosis

Somaia Abdullah Abdel-Sattar;

Abstract


Carvedilol, a third-generation, non-selective β-adrenoreceptor antagonist, possesses antioxidant, anti-apoptotic, anti-inflammatory, and anti-fibrotic properties and used for treatment of portal hypertension. The present study was designed to investigate


Other data

Title Study of the potential antifibrotic effects of carvedilol in exeperimental model of liver fibrosis
Other Titles دراسة التأثيرات المضادة للتليف المحتملة للكارفيديلول على نموذج تجريبى لتليف الكبد
Authors Somaia Abdullah Abdel-Sattar
Keywords Study of the potential antifibrotic effects of carvedilol in exeperimental model of liver fibrosis
Issue Date 2014
Description 
Carvedilol, a third-generation, non-selective β-adrenoreceptor antagonist, possesses antioxidant, anti-apoptotic, anti-inflammatory, and anti-fibrotic properties and used for treatment of portal hypertension. The present study was designed to investigate

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.